Real-time SEC alerts Start Free →
Profitelligence
Cencora Inc.
COR MEDIUM Impact

Cencora Inc.

Cencora Announces Share Repurchase from Walgreens Boots Alliance

| 8-K |Healthcare

Summary

On February 6, 2025, Cencora, Inc. entered into a share repurchase agreement with Walgreens Boots Alliance Holdings LLC, repurchasing 204,491 shares of its common stock for approximately $50 million. The repurchased shares will be held in treasury. This transaction occurred concurrently with Walgreens Boots Alliance's sale of 1,081,885 shares under Rule 144 of the Securities Act of 1933 and the early settlement of certain variable prepaid forward sale contracts. After these transactions, Walgreens Boots Alliance owns 12,570,000 shares of Cencora's common stock, representing approximately 6.5% of the total outstanding shares.

Profitelligence Profitelligence Alerts

Get alerts for COR

Be first to know when Cencora Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Securities Purchase Agreement Share Repurchase Program Announced No viable tag

Exhibits (2)

Advertisement

About Cencora Inc.

Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.

Exchange: NYSE Industry: Medical Distribution Company Website →

Official SEC Documents

COR
COR Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement